Mohnish Suri

Mohnish Suri

Auto-generated profile, based on publicly available information

Mohnish Suri

Clinical Genetics, Nottingham University Hospitals NHS Trust, Nottingham, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FPFélixe Pelletier
Félixe Pelletier
SPStefanie Perrier
Stefanie Perrier
FCFerdy K Cayami
Ferdy K Cayami
AMAmytice Mirchi
Amytice Mirchi
SSStephan Saikali
Stephan Saikali
GBGeneviève Bernard
Geneviève Bernard
Context 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. Objective To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. Design An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. Setting This was a multicenter retrospective study using information collected from 3 predominant centers. Patients A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. Main Outcome Measures Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. Results The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. Conclusions Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder.

1 November 2018 in European Journal of Paediatric Neurology
Verified
Journal Article
Open access
TYT. Michael Yates
T. Michael Yates
MSMohnish Suri
Mohnish Suri
ADArchana Desurkar
Archana Desurkar
GLGaetan Lesca
Gaetan Lesca
CWCarina Wallgren-Pettersson
Carina Wallgren-Pettersson
Meena BalasubramanianMeena Balasubramanian
Meena Balasubramanian
We aim to further delineate the phenotype associated with pathogenic variants in the SLC35A2 gene, and review all published literature to-date. This gene is located on the X chromosome and encodes a UDP-galactose transporter. Pathogenic variants in SLC35A2 cause a congenital disorder of glycosylation. The condition is rare, and less than twenty patients have been reported to-date. The phenotype is complex and has not been fully defined. Here, we present a series of five patients with de novo pathogenic variants in SLC35A2. The patients' phenotype includes developmental and epileptic encephalopathy with hypsarrhythmia, facial dysmorphism, severe intellectual disability, skeletal abnormalities, congenital cardiac disease and cortical visual impairment. Developmental and epileptic encephalopathy with hypsarrhythmia is present in most patients with SLC35A2 variants, and is drug-resistant in the majority of cases. Adrenocorticotropic hormone therapy may achieve partial or complete remission of seizures, but the effect is usually temporary. Isoelectric focusing of transferrins may be normal after infancy, therefore a congenital disorder of glycosylation should still be considered as a diagnosis in the presence of a suggestive phenotype. We also provide evidence that cortical visual impairment is part of the phenotypic spectrum.

21 December 2023 in Brain
Verified
Journal Article
Open access
PDF file
RPRaffaella De Pace
Raffaella De Pace
RMReza Maroofian
Reza Maroofian
APAdeline Paimboeuf
Adeline Paimboeuf
MZMina Zamani
Mina Zamani
MZMaha S Zaki
Maha S Zaki
JBJuan S Bonifacino
Juan S Bonifacino
BLOC-one-related complex (BORC) is a multiprotein complex composed of eight subunits named BORCS1–8. BORC associates with the cytosolic face of lysosomes, where it sequentially recruits the small GTPase ARL8 and kinesin-1 and -3 microtubule motors to promote anterograde transport of lysosomes toward the peripheral cytoplasm in non-neuronal cells and the distal axon in neurons. The physiological and pathological importance of BORC in humans, however, remains to be determined. Here, we report the identification of compound heterozygous variants [missense c.85T>C (p.Ser29Pro) and frameshift c.71-75dupTGGCC (p.Asn26Trpfs*51)] and homozygous variants [missense c.196A>C (p.Thr66Pro) and c.124T>C (p.Ser42Pro)] in BORCS8 in five children with a severe early-infantile neurodegenerative disorder from three unrelated families. The children exhibit global developmental delay, severe-to-profound intellectual disability, hypotonia, limb spasticity, muscle wasting, dysmorphic facies, optic atrophy, leuko-axonopathy with hypomyelination, and neurodegenerative features with prevalent supratentorial involvement. Cellular studies using a heterologous transfection system show that the BORCS8 missense variants p.Ser29Pro, p.Ser42Pro and p.Thr66Pro are expressed at normal levels but exhibit reduced assembly with other BORC subunits and reduced ability to drive lysosome distribution toward the cell periphery. The BORCS8 frameshift variant p.Asn26Trpfs*51, on the other hand, is expressed at lower levels and is completely incapable of assembling with other BORC subunits and promoting lysosome distribution toward the cell periphery. Therefore, all the BORCS8 variants are partial or total loss-of-function alleles and are thus likely pathogenic. Knockout of the orthologous borcs8 in zebrafish causes decreased brain and eye size, neuromuscular anomalies and impaired locomotion, recapitulating some of the key traits of the human disease. These findings thus identify BORCS8 as a novel genetic locus for an early-infantile neurodegenerative disorder and highlight the critical importance of BORC and lysosome dynamics for the development and function of the central nervous system.

1 March 2022 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
MAMarco Angelozzi
Marco Angelozzi
AKAnirudha Karvande
Anirudha Karvande
AMArnaud N Molin
Arnaud N Molin
ARAlyssa L Ritter
Alyssa L Ritter
JLJacqueline M M Leonard
Jacqueline M M Leonard
VLVeronique Lefebvre
Veronique Lefebvre
Background: A neurodevelopmental syndrome was recently reported in four patients with SOX4 heterozygous missense variants in the high-mobility-group (HMG) DNA-binding domain. The present study aimed to consolidate clinical and genetic knowledge of this syndrome. Methods: We newly identified 17 patients with SOX4 variants, predicted variant pathogenicity using in silico tests and in vitro functional assays and analysed the patients’ phenotypes. Results: All variants were novel, distinct and heterozygous. Seven HMG-domain missense and five stop-gain variants were classified as pathogenic or likely pathogenic variant (L/PV) as they precluded SOX4 transcriptional activity in vitro. Five HMG-domain and non-HMG-domain missense variants were classified as of uncertain significance (VUS) due to negative results from functional tests. When known, inheritance was de novo or from a mosaic unaffected or non-mosaic affected parent for patients with L/PV, and from a non-mosaic asymptomatic or affected parent for patients with VUS. All patients had neurodevelopmental, neurological and dysmorphic features, and at least one cardiovascular, ophthalmological, musculoskeletal or other somatic anomaly. Patients with L/PV were overall more affected than patients with VUS. They resembled patients with other neurodevelopmental diseases, including the SOX11-related and Coffin-Siris (CSS) syndromes, but lacked the most specific features of CSS. Conclusion: These findings consolidate evidence of a fairly non-specific neurodevelopmental syndrome due to SOX4 haploinsufficiency in neurogenesis and multiple other developmental processes.

18 December 2024 in Brain
Verified
Journal Article
Open access
GAGabriel N Aughey
Gabriel N Aughey
ECElisa Cali
Elisa Cali
RMReza Maroofian
Reza Maroofian
MZMaha S Zaki
Maha S Zaki
APAlistair T Pagnamenta
Alistair T Pagnamenta
HHHenry Houlden
Henry Houlden
Retinoblastoma (RB) proteins are highly conserved transcriptional regulators that play important roles during development by regulating cell-cycle gene expression. RBL2 dysfunction has been linked to a severe neurodevelopmental disorder. However, to date, clinical features have been described in only six individuals carrying five biallelic predicted loss-of-function (pLOF) variants. To define the phenotypic effects of RBL2 mutations in detail, we identified and clinically characterized a cohort of 35 patients from 20 families carrying pLOF variants in RBL2, including 15 new variants that substantially broaden the molecular spectrum. The clinical presentation of affected individuals is characterized by a range of neurological and developmental abnormalities. Global developmental delay and intellectual disability were observed uniformly, ranging from moderate to profound and involving lack of acquisition of key motor and speech milestones in most patients. Disrupted sleep was also evident in some patients. Frequent features included postnatal microcephaly, infantile hypotonia, aggressive behaviour, stereotypic movements, seizures and non-specific dysmorphic features. Neuroimaging features included cerebral atrophy, white matter volume loss, corpus callosum hypoplasia and cerebellar atrophy. In parallel, we used the fruit fly, Drosophila melanogaster, to investigate how disruption of the conserved RBL2 orthologue Rbf impacts nervous system function and development. We found that Drosophila Rbf LOF mutants recapitulate several features of patients harbouring RBL2 variants, including developmental delay, alterations in head and brain morphology, locomotor defects and perturbed sleep. Surprisingly, in addition to its known role in controlling tissue growth during development, we found that continued Rbf expression is also required in fully differentiated post-mitotic neurons for normal locomotion in Drosophila, and that adult-stage neuronal re-expression of Rbf is sufficient to rescue Rbf mutant locomotor defects. Taken together, our study provides a clinical and experimental basis to understand genotype–phenotype correlations in an RBL2-linked neurodevelopmental disorder and suggests that restoring RBL2 expression through gene therapy approaches might ameliorate some symptoms caused by RBL2 pLOF.

30 September 2021
Verified
Conference Paper
Open access
PDF file
OPOuliana Panagioti
Ouliana Panagioti
EPEmily Petley
Emily Petley
JLJo-Fen Liu
Jo-Fen Liu
Shalini OjhaShalini Ojha
Shalini Ojha
MDMadhumita Dandapani
Madhumita Dandapani
WWWilliam P Whitehouse
William P Whitehouse
Background Patients with Ataxia-Telangiectasia (A-T) are particularly prone to develop different malignancies. Alpha-fetoprotein (AFP) is a useful tumour marker and is well- known to be raised in A-T. Objectives We undertook a systematic review of studies reporting AFP in A-T patients and conducted a retrospective review of AFP levels in children and young people attending the national A-T clinic in Nottingham. Here we present the results of the observational study of AFP levels. Methods Patients’ paper and electronic clinical records were reviewed from 2006–2019 and data extracted. AFP levels of A-T patients who had a malignancy were compared with those who did not have any malignancy. Results Data were available for 77 patients age: 0.9 to 17.2 years; 38 (49.4%) females]. Six (7.8%) had a malignancy. AFP measurements (n=215) ranged from 4 to 1107 kU/L (normal range 0–10 kU/L). Mean AFP in those with a malignancy was 329.9 kU/L (range 6–541; SD 197.6) which was significantly higher than in those without malignancy at 228.8 kU/L (range 4–1107; SD 191.9, p 0.014). Conclusions The AFP levels were significantly higher in those with a malignancy than in those without malignancy. However, 70/71 children without malignancy had AFP levels in the tumour marker range. Time trend analysis is required to investigate if serial AFP measurements might be an early indicator of malignancy in A-T.